These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 16453193

  • 1. Switching from dorzolamide to brinzolamide: effect on intraocular pressure and patient comfort.
    Inoue K, Wada SA, Wakakura M, Inoue J, Tomita G.
    Jpn J Ophthalmol; 2006; 50(1):68-9. PubMed ID: 16453193
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Patients' acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting.
    Barnebey H, Kwok SY.
    Clin Ther; 2000 Oct; 22(10):1204-12. PubMed ID: 11110231
    [Abstract] [Full Text] [Related]

  • 8. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
    Bournias TE, Lai J.
    Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K, Ito K, Okawa C, Sugimoto K, Matsunaga K, Uji Y.
    J Glaucoma; 2008 Sep; 17(3):233-7. PubMed ID: 18414111
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension. Brinzolamide Primary Therapy Study Group.
    Sall K.
    Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S155-62. PubMed ID: 10665518
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension.
    Topouzis F, Goldberg I, Bell K, Tatham AJ, Ridolfi A, Hubatsch D, Nicolela M, Denis P, Lerner SF.
    Eur J Ophthalmol; 2021 Jan; 31(1):103-111. PubMed ID: 31595773
    [Abstract] [Full Text] [Related]

  • 16. Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects.
    Stewart WC, Day DG, Stewart JA, Holmes KT, Jenkins JN.
    Eye (Lond); 2004 Sep; 18(9):905-10. PubMed ID: 15002017
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma.
    Konstas AG, Kozobolis VP, Tersis I, Leech J, Stewart WC.
    Eye (Lond); 2003 Jan; 17(1):41-6. PubMed ID: 12579169
    [Abstract] [Full Text] [Related]

  • 20. Brinzolamide--a new topical carbonic anhydrase inhibitor for glaucoma.
    Med Lett Drugs Ther; 1998 Sep 25; 40(1036):95-6. PubMed ID: 9774966
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.